Russell Investments Group Ltd. lifted its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 58.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 345,273 shares of the pharmacy operator's stock after acquiring an additional 127,800 shares during the quarter. Russell Investments Group Ltd.'s holdings in Walgreens Boots Alliance were worth $3,218,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. First Financial Corp IN lifted its holdings in shares of Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after purchasing an additional 885 shares in the last quarter. Golden State Wealth Management LLC acquired a new stake in Walgreens Boots Alliance during the 4th quarter worth about $26,000. Riverview Trust Co boosted its position in Walgreens Boots Alliance by 123.8% during the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock worth $27,000 after acquiring an additional 1,590 shares during the period. Venturi Wealth Management LLC purchased a new position in Walgreens Boots Alliance during the 4th quarter valued at about $28,000. Finally, Independence Bank of Kentucky acquired a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at about $39,000. Institutional investors and hedge funds own 58.59% of the company's stock.
Analysts Set New Price Targets
Several analysts recently commented on the stock. Wolfe Research upgraded shares of Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. Royal Bank of Canada lifted their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research note on Wednesday, January 15th. Truist Financial dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research note on Friday, January 31st. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a "hold" rating to a "sell" rating and reduced their price objective for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Finally, StockNews.com initiated coverage on Walgreens Boots Alliance in a research note on Saturday. They set a "hold" rating for the company. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $10.59.
Check Out Our Latest Research Report on Walgreens Boots Alliance
Walgreens Boots Alliance Stock Performance
WBA stock traded up $0.12 during midday trading on Tuesday, hitting $10.99. 10,775,459 shares of the company traded hands, compared to its average volume of 21,036,217. The business has a 50 day simple moving average of $10.90 and a 200-day simple moving average of $10.17. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $18.83. The stock has a market capitalization of $9.50 billion, a price-to-earnings ratio of -1.07, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping the consensus estimate of $0.53 by $0.10. The firm had revenue of $38.59 billion for the quarter, compared to the consensus estimate of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business's quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.20 EPS. As a group, equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.
Walgreens Boots Alliance Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Articles

Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.